Caspase-11 signaling enhances graft-versus-host disease by Lu, Y. et al.
Journal Articles 
2019 
Caspase-11 signaling enhances graft-versus-host disease 
Y. Lu 
R. Meng 
X. Wang 
Y. Xu 
Y. Tang 
See next page for additional authors 
Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles 
 Part of the Emergency Medicine Commons 
Recommended Citation 
Lu Y, Meng R, Wang X, Xu Y, Tang Y, Wu J, Xue Q, Yu S, Wang H, Lu B. Caspase-11 signaling enhances 
graft-versus-host disease. . 2019 Jan 01; 10(1):Article 4998 [ p.]. Available from: 
https://academicworks.medicine.hofstra.edu/articles/4998. Free full text article. 
This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic 
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara 
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu. 
Authors 
Y. Lu, R. Meng, X. Wang, Y. Xu, Y. Tang, J. Wu, Q. Xue, S. Yu, H. Wang, and B. Lu 
This article is available at Donald and Barbara Zucker School of Medicine Academic Works: 
https://academicworks.medicine.hofstra.edu/articles/4998 
ARTICLE
Caspase-11 signaling enhances graft-versus-host
disease
Yanyan Lu1, Ran Meng1, Xiangyu Wang1, Yajing Xu2, Yiting Tang3, Jianfeng Wu4, Qianqian Xue1, Songlin Yu1,
Mingwu Duan1, Dongyong Shan1, Qingde Wang5, Haichao Wang 6, Timothy R. Billiar5, Xianzhong Xiao7,8,
Fangping Chen1 & Ben Lu 1,7,8
Acute graft-versus-host disease (GVHD) remains a major obstacle for the wider usage of
allogeneic hematopoietic stem cell transplantation (allo-HSCT), which is an effective therapy
for hematopoietic malignancy. Here we show that caspase-11, the cytosolic receptor for
bacterial endotoxin (lipopolysaccharide: LPS), enhances GVHD severity. Allo-HSCT markedly
increases the LPS-caspase-11 interaction, leading to the cleavage of gasdermin D (GSDMD).
Caspase-11 and GSDMD mediate the release of interleukin-1α (IL-1α) in allo-HSCT. Deletion
of Caspase-11 or Gsdmd, inhibition of LPS-caspase-11 interaction, or neutralizing IL-1α uni-
formly reduces intestinal inflammation, tissue damage, donor T cell expansion and mortality
in allo-HSCT. Importantly, Caspase-11 deficiency does not decrease the graft-versus-leukemia
(GVL) activity, which is essential to prevent cancer relapse. These findings have major
implications for allo-HSCT, as pharmacological interference with the caspase-11 signaling
might reduce GVHD while preserving GVL activity.
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The success of allogeneic hematopoietic stem cell trans-plantation (allo-HSCT), a standard therapy for conditionssuch as hematopoietic malignancies and inherited hema-
topoietic disorders, is limited by the mortality and morbility
associated with graft-versus-host disease (GVHD)1,2. In allo-
HSCT, irradiation- or chemotherapy-induced gastrointestinal
(GI) damage allows the translocation of bacteria or lipopoly-
saccharide (LPS), the major cell-wall component of Gram-
negative bacteria, from GI tract into the systemic circulation1,3.
Serum and tissue levels of LPS are closely correlated with GVHD
severity and mortality3,4. LPS antagonism reduces GVHD while
preserving graft-versus-leukemia (GVL) activity in experimental
models5. Further, antibodies against LPS or Gram-negative bac-
teria significantly reduces the incidence of GVHD in clinical
trials6,7. It has been proposed that LPS or Gram-negative bacteria
enhance GVHD through toll-like receptor 4 (TLR4), a well-
established cell surface LPS receptor. However, allo-HSCT reci-
pient mice that express a signaling-deficient Tlr4 mutant devel-
oped fulminant GVHD and increased intestinal damage
compared to their wild-type (WT) counterparts8. These obser-
vations raise a possibility that LPS or Gram-negative bacteria
might enhance GVHD through TLR4-independent signaling
pathways.
Caspase-11 is a cytosolic LPS receptor that senses various
Gram-negative bacteria infections9–15. Upon activation by intra-
cellular LPS, caspase-11 oligomerizes into protein complexes and
enzymatically cleaves gasdermin D (GSDMD) into pore-forming
peptides, leading to a lytic form of cell death, termed pyr-
optosis16–18. This process destroys the intracellular niche for
microbes and triggers inflammation by releasing alarmins, such as
interleukin-1α (IL-1α)12,13,15. Loss of caspase-11 renders mice
susceptible to Burkholderia pseudomallei, a Gram-negative bac-
terium endemic to Southeast Asia that causes melioidosis12.
However, over-activation of caspase-11 in endotoxemia or poly-
microbial sepsis leads to organ injury and lethality10,19–22. Dys-
regulated activation of caspase-11 also contributes to the
pathogenesis of age-related macular degeneration23. Based on
these findings and the demonstrated role of LPS in the develop-
ment of GVHD, we hypothesize that caspase-11 signaling con-
tributes to the pathogenesis of GVHD in allo-HSCT.
In this study, we show that the LPS–caspase-11 interaction is
important for the development of GVHD in allo-HSCT. Recog-
nition of LPS by caspase-11 leads to the cleavage of GSDMD,
which is essential for the release of IL-1α after bone marrow
transplantation (BM). Disruption of the LPS–caspase-11 inter-
action, deletion of Caspase-11 or Gsdmd, or neutralization of IL-
1α uniformly reduces intestinal inflammation, donor T cell
expansion, and mortality in allo-HSCT. Moreover, Caspase-11
deficiency does not compromise the GVL effect. These findings
suggest that pharmacological inhibition of the caspase-11 sig-
naling might reduce GVHD while preserving GVL activity in
allo-HSCT.
Results
Caspase-11 enhances GVHD in allo-HSCT. To determine the
role of caspase-11 in GVHD following allo-HSCT, T cells purified
from WT mice (on a BALB/c background, H2d) were trans-
planted together with BM into lethally irradiated major histo-
compatibility complex (MHC)-mismatched WT or Caspase-11-
deficient recipient mice (on a B6 background, H2b, provided by
the University of Pittsburgh). We observed that genetic deletion
of Caspase-11 in recipients significantly improved survival
(Fig. 1a). These findings were reproduced when we used a dif-
ferent strain of Caspase-11-deficient mice (on a B6 background,
from the Jackson laboratory) or their WT littermates (Fig. 1b).
Furthermore, similar observations were made when mice were
pre-conditioned with busulfan and cyclophosphamide (BU/CY)
chemotherapy (Fig. 1c). Caspase-11-deficient recipients had
markedly fewer pathological injuries (in liver, lung, small intes-
tine, and colon) (Fig. 1d), and displayed significantly lower
GVHD pathological scores compared with WT controls (Fig. 1e
and Supplementary Fig. 1a). However, pre-transplant radiation
resulted in similar weight loss and tissue injury in Caspase-11-
deficient recipients and their WT controls (Supplementary Fig.
1b, c). We next examined whether caspase-11 in donor cells
contributes to the pathogenesis of GVHD. Purified T cells and
BM from Caspase-11-deficient mice or their WT littermates (on a
B6 background, H2b) were transplanted into lethally irradiated
recipient mice on a BALB/c background (H2d). Deletion of
Caspase-11 in donor cells resulted in a delayed mortality and
slightly improved GVHD pathological scores in WT recipients
(Fig. 1f and Supplementary Fig. 1d, e). We established that
caspase-11 expressed in the non-hematopoietic compartment
plays the dominant role in promoting GVHD lethality in allo-
HSCT, while caspase-11 expressed in the hematopoietic com-
partment plays a minor role (Supplementary Fig. 1f). Caspase-11
deficiency in both recipients and donor BM cells further
decreased allogeneic T cell-mediated lethality (Supplementary
Fig. 1f).
Caspase-11 enhances donor T cell expansion. The tissue injury
associated with GVHD is caused by the activation of allogeneic
donor T cells. To test whether caspase-11 enhances allogeneic
donor T cell expansion following HSCT, we used BALB/c donor
T cells that express luciferase linked to the β-actin promoter. Two
weeks after allo-HSCT, Caspase-11-deficient or WT recipients
were subjected to bioluminescence (bioluminescent imaging
(BLI)) to measure donor T cell expansion. Quantification of
whole-body or intestinal BLI intensity indicated that Caspase-11-
deficient recipients had significantly reduced T cell expansion, as
compared to that of WT recipients (Fig. 2a, b). Activation of
allogeneic T cells in GVHD is associated with increased pro-
duction of interferon-γ (IFN-γ) and other proinflammatory
cytokines, such as IL-17. Neutrophil recruitment into the tissues
promotes allogeneic donor T cell expansion and exacerbates
GVHD-related tissue injury and mortality1. In line with these
findings, serum levels of IFN-γ and neutrophil infiltration in the
colon of Caspase-11-deficient recipients were significantly lower
than those in WT recipients (Fig. 2c, d). Caspase-11 deficiency in
recipient mice was also associated with significantly lower serum
levels of IL-17 and IL-6 (Supplementary Fig. 2a–c) following allo-
HSCT. Deletion of Caspase-11 significantly inhibited CD4 T cell
T-helper type 1 (Th1) and Th17 polarization in the intestine
(Supplementary Fig 2d, e). Taken together, our data demonstrate
that Caspase-11 promotes neutrophil infiltration, intestinal
inflammation, tissue damage, donor T cell expansion and mor-
tality in allo-HSCT.
LPS–caspase-11 interaction enhances GVHD. Caspase-11 is a
cytosolic LPS receptor that is constitutively expressed in intestinal
tissues24. To assess the LPS–caspase-11 interaction in allo-HSCT,
we performed the proximity-ligation assay (PLA) that visualizes
the physical interaction between two molecules22. Allo-HSCT
markedly increased the LPS–caspase-11 interaction in the intes-
tine of WT mice (Fig. 3a). As expected, the interaction was lost
with genetic deletion of Caspase-11 (Fig. 3a). LPS–caspase-11
complexes predominantly co-localized with an epithelial marker
(Supplementary Fig. 3a), further supporting the notion that
caspase-11 expressed in the non-hematopoietic compartment
plays the dominant role in promoting GVHD following
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allo-HSCT. Recognition of LPS by caspase-11 requires guanylate-
binding proteins (GBPs)13,25. In line with these findings,
LPS–caspase-11 interaction in the intestinal epithelium was not
observed when GBPchr3 KO (knockout) mice13, which lack
GBP1, 2, 3, 5, and 7, were used as HSCT recipients (Fig. 3b). We
also observed that deletion of GBPs in recipients significantly
improved survival (Fig. 3c), and markedly reduced serum levels of
IFN-γ as well as neutrophil infiltration into the colon (Supple-
mentary Fig. 3b, c). Accordingly, GBPchr3 KO recipients dis-
played significantly improved GVHD pathological scores as
compared to WT recipients (Fig. 3d and Supplementary Fig. 3d).
GBPchr3 KO recipients also exhibited reduced T cell expansion
to a level similar to that seen in Caspase-11-deficient recipients
(Fig. 3e, f).
To further confirm that the interaction of LPS with caspase-11
promotes GVHD, mice were treated with LPS from the
photosynthetic bacterium Rhodobacter sphaeroides (LPS-RS),
the penta-acylated LPS that competitively inhibits the
LPS–caspase-11 interaction22 (Supplementary Fig. 3a). Treatment
of LPS-RS significantly promoted survival in WT but not
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GBPchr3 KO recipient mice following allo-HSCT (Fig. 3g).
Conversely, intraperitoneal (i.p.) administration of LPS after allo-
HSCT significantly promoted GVHD lethality in WT but not in
Caspase-11-deficient or GBPchr3 KO recipient mice (Fig. 3h).
Oral administration of ciprofloxacin significantly decreased the
circulating LPS levels (Supplementary Fig. 4a, b). Accordingly,
ciprofloxacin treatment significantly improved survival in WT
but not in Caspase-11-deficient recipient mice (Supplementary
Fig. 4c). Taken together, these data indicate that LPS–caspase-11
interaction enhances GVHD in allo-HSCT.
Fig. 1 Caspase-11 (Casp11) enhances graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). a Percentage
survival of Casp11+/+ recipient mice versus Casp11−/− recipient mice (BALB/c→ C57BL/6 combination) receiving BALB/c bone marrow (BM) and T cells is
shown (n= 12 in each group). (***P= 0.0008; differences in animal survival were analyzed by log-rank test). b Survival of Casp11+/+ and Casp11−/− (Jax)
recipients receiving allo-HSCT from BALB/c donors after TBI (total body irradiation) based conditioning is shown (n= 10 in each group) (**P= 0.0022;
differences in animal survival were analyzed by log-rank test). c Survival of Casp11+/+ recipient mice versus Casp11−/− recipient mice receiving allo-HSCT
from BALB/c donors after chemotherapy (busulfan/cyclophosphamide (BU/CY))-based conditioning is shown (n= 12 in each group). The experiment was
performed twice and data were pooled. (****P < 0.0001, differences in animal survival were analyzed by log-rank test). d Photomicrographs depicting the
average disease score morphology from one representative experiment out of two separate experiments are depicted. Scale bar: 100 μm. BM represents
C57BL/6 recipients receiving BALB/c BM group. Casp11+/+ and Casp11−/− recipients represent mice receiving BALB/c BM and T cells group. e Histological
analysis of the small intestines, large intestines, and liver from Casp11+/+ and Casp11−/− recipient mice receiving BALB/c BM and T cells for GVHD severity
on day 14. Data are presented as mean ± SEM. *P < 0.05. An unpaired Student’s t test (two-sided) was used. f Survival of wild-type (WT) recipient mice
(C57BL/6→ BALB/c combination) receiving Casp11+/+ versus Casp11−/− BM with or without T cells is shown. The experiment was performed twice and the
results were pooled. Casp11+/+ versus Casp11−/− (**P= 0.0054; differences in animal survival were analyzed by log-rank test)
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Fig. 2 Caspase-11 enhances donor T cell expansion in allogeneic hematopoietic stem cell transplantation (allo-HSCT). a Fourteen days post transplant,
Casp11+/+ and Casp11−/− recipients receiving BALB/c bone marrow and T cells were subjected to intraperitoneal luciferin injection and whole-body
bioluminescent imaging (BLI) are depicted. Region of interest gating and signal normalization with Living Image software. Average representative whole-
body images, and average bioluminescence intensities ± SEM were depicted. (**P= 0.0040; an unpaired Student’s t test (two-sided) was used).
b Fourteen days post transplant, Casp11+/+ and Casp11−/− recipients receiving BALB/c bone marrow and T cells were subjected to intraperitoneal luciferin
injection and whole-body BLI followed by a second luciferin injection, euthanization, organ removal, and BLI of graft-versus-host disease (GVHD) target
organs of intestines. Bioluminescence was quantified using whole organ region of interest gating and signal normalization with Living Image software.
Average representative ex vivo organ images, and average bioluminescence intensities ± SEM were depicted. (**P= 0.0089; an unpaired Student’s t test
(two-sided) was used). c Interferon-γ (IFN-γ) in the serum of mice receiving BM and T cells (groups described in a, BALB/C (donor), C57BL/6 (recipient)
model, day 5 after allo-HSCT). Data (mean ± SEM) are pooled from two independent experiments (****P < 0.0001, an unpaired Student’s t test (two-sided)
was used). d Representative colon tissue section of Casp11+/+ recipient mice versus Casp11−/− recipient mice (BALB/c→ C57BL/6 combination) receiving
BALB/c bone marrow and T cells is shown. Staining in brown is for myeloperoxidase as indicated for the respective tissues. The frequency of
myeloperoxidase positive (MPO+) cells per high power field (HPF) was significantly lower in the caspase-11-deficient recipients than those of in wild-type
(WT) recipients. Data are presented as mean ± SEM (***P= 0.0008, an unpaired Student’s t test (two-sided) was used). Scale bar: 100 μm
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Caspase-11 enhances GVHD through GSDMD. GSDMD is a
caspase-11 substrate that directly triggers pyroptosis16,17. Allo-
HSCT leads to the cleavage of GSDMD in the intestine in WT
recipients. Deletion of Caspase-11 or GBPs in recipient mice
markedly decreased GSDMD cleavage in allo-HSCT (Fig. 4a).
Treatment of LPS-RS significantly inhibited and LPS adminis-
tration enhanced GSDMD cleavage in the intestine after allo-
HSCT (Fig. 4a). Next, we determined whether caspase-11
enhances GVHD through GSDMD in the MHC-mismatched
allo-HSCT. Deletion of Gsdmd significantly improved survival
(Fig. 4b), and markedly reduced serum IFN-γ levels (Supple-
mentary Fig. 5a) and intestinal neutrophil infiltration (Supple-
mentary Fig. 5b). Gsdmd deficiency significantly improved
GVHD pathological scores in a manner similar to Caspase-11
deficiency (Fig. 4c and Supplementary Fig. 5c) and was associated
with reduced T cell expansion as using luciferase-expressing
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T cells as described above (Fig. 4d). Treatment of LPS-RS sig-
nificantly promoted survival in WT but not in Gsdmd KO reci-
pient mice during allo-HSCT (Fig. 4e). Further, LPS treatment
significantly promoted lethality in WT but not in Gsdmd KO
recipient mice during allo-HSCT (Fig. 4f). These findings show
that caspase-11 promotes GVHD through GSDMD in allo-HSCT.
Caspase-11 and GSDMD mediates IL-1α release in GVHD.
Caspase-11 activation and subsequent GSDMD cleavage lead to
the release of IL-1α in endotoxemia and bacterial sepsis10,16,22.
We next determined whether caspase-11 and GSDMD mediates
IL-1α release in GVHD. Serum levels of IL-1α were significantly
increased in allo-HSCT (Fig. 5a–c). Deletion of Caspase-11 or
Gsdmd in recipients markedly reduced IL-1α release, indicating
that caspase-11- and GSDMD-expressing non-hematopoietic
cells (e.g., epithelial cells) are the major source of IL-1α after allo-
HSCT (Fig. 5a–c). Serum levels of IL-1α were correlated with
GVHD pathological scores in mouse models (Fig. 5d). Impor-
tantly, we prospectively analyzed the serum levels of 50 patients
undergoing allo-HSCT (Supplementary Table 1) and found that
the serum levels of IL-1α in patients with severe GVHD were
significantly higher than those in patients with no or mild GVHD
(Fig. 5e). Together, these findings indicate that caspase-11 and
GSDMD mediates IL-1α release in GVHD.
Neutralizing IL-1α attenuates GVHD. Next, we tested whether
caspase-11 signaling enhances GVHD in allo-HSCT through
releasing IL-1α. Neutralizing IL-1α using monoclonal antibodies,
which almost completely depleted IL-1α in serum (Fig. 6a), led to
a marked improvement of GVHD mortality and a significant
reduction of GVHD pathological scores (Fig. 6b, c). Meanwhile,
administration of IL-1α-neutralizing antibodies significantly
decreased serum IFN-γ levels (Fig. 6d), and reduced donor T cell
expansion in the whole body and small intestine as compared to
their WT littermates (Fig. 6e, f). Importantly, neutralizing IL-1α
significantly improved survival in allo-HSCT in WT mice but not
in Caspase-11-deficient recipients (Supplementary Fig. 6a). Cas-
pase-11- and GSDMD-induced pyroptosis leads to potassium
efflux, resulting in the activation of NLRP3 inflammasome16. This
event mediates the maturation of IL-1β, which has similar bio-
logical functions as IL-1α. In agreement with a previous study26,
Nlrp3 deficiency in recipients delayed but did not reduce mor-
tality when mice were injected with 106 allogeneic donor T cells,
whereas Caspase-11-deficiency significantly reduced mortality in
the same experimental setting (Supplementary Fig. 6b). Caspase-
11 and GSDMD were also critical for IL-18 release in allo-HSCT
(Supplementary Fig. 6c, d). However, genetic deletion of Il-18
failed to affect the survival (Supplementary Fig. 6e). Together,
these observations suggest that caspase-11 signaling enhances
GVHD, at least in part, through IL-1α.
We next investigated the mechanisms by which IL-1α
promotes donor T cell expansion and GVHD severity. Admin-
istration of IL-1α-neutralizing antibodies markedly reduced
intestinal neutrophil infiltration in allo-HSCT (Supplementary
Fig. 7a). In agreement with a previous study1, depletion of
neutrophils using anti-Ly-6G antibodies significantly improved
survival and markedly inhibited donor T cell expansion in allo-
HSCT (Supplementary Fig. 7b, c). These findings suggest that IL-
1α promotes neutrophil infiltration in allo-HSCT, which is critical
for donor T cell expansion and GVHD severity.
Caspase-11 deficiency preserves GVL activity. GVL activity is
essential for preventing tumor relapse, and is the key to the success
of allo-HSCT27. Thus, we next determined whether Caspase-11
deficiency in recipients affects GVL maintenance by using allo-
HSCT model supplemented with EL4 murine T lymphoma cells
transduced with luciferase/neo plasmid (EL4-luc) for BLI tumor
tracking. Six weeks after MHC-mismatched allo-HSCT, GVHD
versus tumor mortality was distinguished by the BLI signal
(indicative of tumor load) and weight loss (indicative of GVHD
onset). As expected, all recipients of EL4-luc and BM succumbed
to tumor within 4 weeks (Fig. 7a). WT recipients of allogeneic
T cells all succumbed to GVHD by day 30 after allo-HSCT in
parallel with notable weight loss (Fig. 7b). These mice lacked a
tumor BLI signal and visible tumor (Fig. 7c). Deletion of Caspase-
11 in recipients significantly improved both weight maintenance
and survival (Fig. 7a–c). Remarkably, none of the Caspase-11-
deficient mice succumbed to tumor (Fig. 7a and Supplementary
Fig. 8). These findings demonstrate that Caspase-11 deficiency
does not compromise the GVL effect in allo-HSCT.
Discussion
Taken together, this study establishes that blocking caspase-11
signaling reduces GVHD while preserving GVL activity. In this
scenario, circulating LPS or Gram-negative bacteria activate
caspase-11 through GBPs, leading to GSDMD-dependent IL-1α
release. Targeting this pathway by genetic or pharmacological
approaches reduced intestinal neutrophil infiltration, tissue
damage, and donor T cell expansion in allo-HSCT. Together with
Fig. 3 Lipopolysaccharide (LPS)–caspase-11 interaction enhances graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation
(allo-HSCT). a The physical interactions between caspase-11 and LPS were visualized as the red spots by proximity-ligation assay (PLA) in the intestinal
tissues in Casp11+/+ and Casp11−/− recipient mice receiving BALB/c bone marrow and T cells. Scale bar: 10 μm. Data are presented as mean ± SEM (***P <
0.001, an unpaired Student’s t test (two-sided) was used). b The physical interactions between caspase-11 and LPS were visualized as the red spots by PLA
in the intestinal tissues in Gbpchr3+/+ and Gbpchr3−/− recipient mice receiving BALB/c bone marrow and T cells. Scale bar: 10 μm. Data are presented as
mean ± SEM (**P < 0.01, an unpaired Student’s t test (two-sided) was used). c Survival of C57BL/6 mice is shown (Gbpchr3+/+ versus Gbpchr3−/−, **P=
0.0045; differences in animal survival were analyzed by log-rank test). d Histopathological GVHD severity of C57BL/6 mice after receiving BALB/c bone
marrow and T cells (BALB/c→ C57BL/6) is shown (Gbpchr3+/+ versus Gbpchr3−/−). Data are presented as mean (**P < 0.01; ***P < 0.001; an unpaired
Student’s t test (two-sided) was used). e Fourteen days post transplant, Gbpchr3+/+ and Gbpchr3−/− recipients were subjected to intraperitoneal luciferin
injection and whole-body bioluminescent imaging (BLI) are depicted. Average representative whole-body images and bioluminescence intensities ± SEM
are depicted (**P= 0.0013; an unpaired Student’s t test (two-sided) was used). f Fourteen days post transplant, Gbpchr3+/+ and Gbpchr3−/− recipients
were subjected to intraperitoneal luciferin injection, whole-body BLI, and BLI of intestines. Average representative ex vivo organ images and average
bioluminescence intensities ± SEM are depicted (**P= 0.0034; an unpaired Student’s t test (two-sided) was used). g Percentage survival of Gbpchr3+/+
and Gbpchr3−/− recipient mice receiving BALB/c bone marrow and T cells with treatment of lipopolysaccharide from the photosynthetic bacterium
Rhodobacter sphaeroides (LPS-RS) or saline is shown. Differences in animal survival were analyzed by log-rank test. (Gbpchr3+/+ + saline versus Gbpch3−/−
+ saline, ****P < 0.0001; Gbpchr3+/+ + saline versus Gbpchr3+/+ + LPS-RS, ****P < 0.0001; Gbpchr3+/+ + saline versus Gbpchr3−/− + LPS-RS,
****P < 0.0001). h Percentage survival of Gbpchr3+/+ and Gbpchr3−/− recipient mice with multiple injections of LPS or saline is shown. Differences
in animal survival were analyzed by log-rank test. (Gbpchr3+/++ saline versus Gbpchr3−/−+ saline, ***P= 0.0004.; Gbpchr3+/++ saline versus
Gbpchr3+/++ LPS, ****P < 0.0001; Gbpchr3+/++ saline versus Gbpchr3−/−+ LPS, ***P= 0.0002)
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a recent finding that gut microbiota-induced neutrophil recruit-
ment to the intestinal tissue promotes donor T cell activation and
contributes to the pathogenesis of GVHD1, our data shed
mechanistic insights into how gut microbiota promotes GVHD in
allo-HSCT. The important contribution of gut microbiota to
GVHD was first discovered in the 1970s. It then became a
common practice to perform intestinal decontamination using
orally administered antibiotics in patients undergoing allo-
HSCT27. Initial reports were promising, but subsequent studies
could not confirm a benefit27. Broad-spectrum antibiotic use even
promotes GVHD by causing dysbiosis28. Furthermore, gut
microbiota-derived metabolites, such as butyrate, improve
intraepithelial cell junctional integrity, decreases apoptosis, and
mitigates GVHD29. Therefore, pharmacologically targeting gut
microbiota-induced inflammatory responses, such as the caspase-
11 signaling, might be a more effective option for patients
undergoing allo-HSCT than eliminating bacterial colonies in the
GI tract through antibiotics.
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Fig. 4 Caspase-11 enhances graft-versus-host disease (GVHD through gasdermin D (GSDMD) in allogeneic hematopoietic stem cell transplantation (allo-
HSCT). a Immunoblot for GSDMD and β-actin in the intestine from wild-type (WT) (C57BL/6), Gbpchr3−/− or Gsdmd−/− recipients mice with treatment
of lipopolysaccharide (LPS) or lipopolysaccharide from the photosynthetic bacterium Rhodobacter sphaeroides (LPS-RS). b Survival of Gsdmd+/+ versus
Gsdmd−/− recipient mice (BALB/c→ C57BL/6 combination) receiving BALB/c bone marrow and T cells is shown. The experiment was performed twice
and the results were pooled. Gsdmd+/+ versus Gsdmd−/−, ***P= 0.0002; differences in animal survival were analyzed by log-rank test. c Histological
analysis of the small intestines, large intestines, and liver from Gsdmd+/+ and Gsdmd−/− recipient mice receiving BALB/c bone marrow and T cells for
GVHD severity on day 14. Data are presented as mean ± SEM. **P < 0.01; *P < 0.05. An unpaired Student’s t test (two-sided) was used. d Fourteen days
post transplant, Gsdmd+/+ and Gsdmd−/− recipients receiving BALB/c bone marrow and T cells were subjected to intraperitoneal luciferin injection and
whole-body bioluminescent imaging (BLI) are depicted. Average representative whole-body images and average bioluminescence intensities ± SEM were
depicted. Data are presented as mean ± SEM. An unpaired Student’s t test (two-sided) was used. **P < 0.01(compared with vehicle-treated controls).
e Percentage survival of Gsdmd+/+ and Gsdmd−/− recipient mice receiving BALB/c bone marrow and T cells (BALB/c→ C57BL/6 combination) with
treatment of LPS-RS or saline is shown. Differences in animal survival were analyzed by log-rank test. (Gsdmd+/++ saline versus Gsdmd−/−+ saline,
****P < 0.0001; Gsdmd+/++ saline versus Gsdmd+/++ LPS-RS, ****P < 0.0001; Gsdmd+/++ saline versus Gsdmd −/−+ LPS-RS, ****P < 0.0001).
f Percentage survival of Gsdmd+/+ and Gsdmd−/− recipient mice receiving BALB/c bone marrow and T cells (BALB/c→ C57BL/6 combination) with
multiple injections of LPS or saline is shown. Differences in animal survival were analyzed by log-rank test. (Gsdmd+/++ saline versus Gsdmd−/−+ saline,
***P= 0.0005; Gsdmd+/++ saline versus Gsdmd+/++ LPS, ****P < 0.0001; Gsdmd+/++ saline versus Gsdmd−/− + LPS, ***P= 0.0004)
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Fig. 5 Caspase-11 and gasdermin D (GSDMD) mediate interleukin-1α (IL-1α) release in graft-versus-host disease (GVHD). a–c Total body irradiation (1100
cGy) was dosed to C57BL/6 mice, which were then transplanted with 5 × 106 wild-type (WT) BALB/c T cell-depleted bone marrow (TCD-BM) cells alone
or in addition to 5 × 106 total T cells on day 0. Five days post transplant, serum was subjected to cytokine analysis to quantify serum cytokine
concentrations of IL-1α in Casp11−/− (a) Gbpchr3−/− (b) and Gsdmd−/− (c) recipients. An unpaired Student’s t test (two-sided) was used. **P < 0.01;
****P < 0.0001 (compared with vehicle-treated controls). d The serum IL-1α levels of Casp11+/+ and Casp11−/− recipients that had undergone allogeneic
hematopoietic stem cell transplantation (allo-HSCT) was correlated with GVHD severity. An unpaired Student’s t test (two-sided) was used. **P < 0.01;
***P < 0.001. e The levels of IL-1α in the serum was correlated with the GVHD severity (GVHD grade 0, n= 13; GVHD grade I–II, n= 17; GVHD grade III–IV,
n= 20) in patients after allo-HSCT. ****P < 0.0001. An unpaired Student’s t test (two-sided) was used. The patients’ characteristics are detailed in
Supplementary Table 1
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Fig. 6 Neutralizing interleukin-1α (IL-1α) attenuates graft-versus-host disease (GVHD). a Levels of IL-1α in the serum are shown from mice bone marrow
(BM) receiving BALB/c BM or injected with 4 µg per mouse anti-IL-1α monoclonal antibody (Ab) or isotype control Ab per mouse on day −1 and day +1 of
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Scatter plot represent mean, n= 4 (BM), n= 10 (IL-1α Ab) and n= 7 (isotype control)
with results pooled from two independent experiments. ****P < 0.0001, unpaired Student’s t test (two-sided). b Survival of C57BL/6 recipients (BALB/c→
C57BL/6 combination) is shown for a group that received BM/Tc (BM/T cell) with anti-IL-1α monoclonal Ab or isotype control Ab. BM/Tc+ isotype
control Ab (n= 11) versus BM/Tc+ anti-IL-1α monoclonal Ab (n= 10), **P= 0.0065. Differences in animal survival were analyzed by log-rank test.
c Histological analysis of the small intestines, large intestines, and liver from anti-IL-1α monoclonal Ab and isotype control Ab mice for GVHD severity on
day 14. Data are presented as mean ± SEM. An unpaired Student’s t test (two-sided) was used. *P < 0.05; **P < 0.01. d Levels of interferon-γ (IFN-γ) in the
serum of the BM/Tc+ isotype control Ab (n= 9) and BM/Tc+ anti-IL-1α monoclonal Ab recipient mice (n= 9) on the day 5 after allo-HSCT. ****P <
0.0001. An unpaired Student’s t test (two-sided) was used. e Fourteen days post transplant, BM/Tc+ isotype control Ab and BM/Tc+ anti-IL-1α
monoclonal Ab recipients were subjected to intraperitoneal luciferin injection and whole-body bioluminescent imaging (BLI) are depicted. Average
representative whole-body images, and average bioluminescence intensities ± SEM were depicted. An unpaired Student’s t test (two-sided) was used.
**P < 0.01 (compared with vehicle-treated controls). f Fourteen days post transplant, BM/Tc+ isotype control Ab and BM/Tc+ anti-IL-1α monoclonal Ab
recipients were subjected to intraperitoneal luciferin injection, whole-body BLI and BLI of intestines. Average representative ex vivo organ images, and
average bioluminescence intensities ± SEM were depicted. An unpaired Student’s t test (two-sided) was used. ***P= 0.0003 (compared with vehicle-
treated controls)
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Fig. 7 Caspase-11 deficiency preserves graft-versus-leukemia (GVL) activity. a Survival of Casp11+/+ (n= 12) and Casp11−/− (n= 11) recipients had received
lethally irradiation (1100 cGy) and transplanted with 5 × 106 BALB/c T cell-depleted bone marrow (TCD-BM) cells alone or in addition to 3 × 106 total
T cells from BALB/c mice with 3 × 105 EL4 luciferase-transduced lymphoma cells at the time BM transplant (BMT) was shown. Differences in animal
survival were analyzed by log-rank test. **P= 0.0039 (Casp11−/− compared with vehicle-treated controls). b Casp11+/+ (n= 12) and Casp11−/− (n= 11)
recipients were monitored throughout the experimental period for weight change by every 3 to 5 days. c Tumor expansion in Casp11+/+ and Casp11−/−
recipients was shown by luciferin intraperitoneal injection and whole-body bioluminescent imaging (BLI) was taken every 14 days
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Type 1 IFN signaling is important for the activation of caspase-
1111,13,15. Priming with poly I:C, a double-stranded RNA mimetic
that induces robust type 1 IFN production in a manner similar to
that of double-stranded RNA virus, could significantly promote
LPS-induced caspase-11 activation and pyroptosis in lung endo-
thelial cells21. Further, administration of poly I:C markedly increases
caspase-11-dependent lethality in endotoxemia19,20. Recent advan-
ces reveal a progressive expansion of viral infections over time fol-
lowing allo-HSCT30. In particular, the picobirnaviruses, which are
double-stranded RNA virus, are strongly associated with severe
enteric GVHD30. These findings raise an intriguing possibility that
allo-HSCT-associated viral infections might enhance GVHD
through the caspase-11-GSDMD signaling. It is noteworthy that
caspase-1 also mediates GSDMD cleavage. Both gut microbiota and
viral infections are able to activate caspase-1 through canonical
inflammasomes. Thus, the roles of caspase-1 in the pathogenesis of
GVHD in allo-HSCT merit further investigations.
GVHD remains a major obstacle for the wider usage of allo-
HSCT1,2. To date, most therapeutic or prophylactic strategies to
prevent severe GVDH include T cell depletion, pharmacological
inhibition of T cell activation and proliferation, and intervene with
the T cell-dependent effector phase27. These approaches inevitably
impair the global host immunity, and thus compromise the GVL
activity mediated by donor T cells, which is the major determinant
of the overall outcome after allo-HSCT27. In the current study, we
show that the absence of caspase-11 signaling reduces GVHD while
preserving GVL activity. Therefore, our data have major implica-
tions for allo-HSCT, as pharmacological inhibition of caspase-11
signaling might exclusively reduce the unwanted graft-versus-host
reactions while sparing the beneficial GVL activity in allo-HSCT.
Methods
Human subjects. Serum samples were collected at 30 to 80 days after GVHD
diagnosis, in accordance with research ethics board approval from Xiangya Hos-
pital of Central South University (CSU). All patients provided informed consent to
data collection for research. Patient characteristics are given in Supplementary
Table 1. GVHD grading was performed on the basis of Glucksberg grade standard.
Mice. C57BL/6 (H-2Kb, Thy-1.2) and BALB/c (H-2Kd, Thy-1.2) mice were pur-
chased from Hunan SJA Laboratory Animal Co. (Changsha, China). Caspase11−/−,
Il-18−/−, and L2G85.BALB/c mice were purchased from Jackson laboratory. The
Caspase11−/− mice22 were donated by Timothy R. Billiar (Department of Surgery,
University of Pittsburgh Medical Center, Pittsburgh, PA). The GBPchr3−/− mice31
were donated by Petr Broz (Focal Area Infection Biology, Biozentrum, University
of Basel). The Gsdmd−/− mice32 were donated by Jiahuai Han (State Key
Laboratory of Cellular Stress Biology Innovation Center for Cell Signaling Network
School of Life Sciences, Xiamen University). The Nlrp3−/− mice33 were donated by
Rongbin Zhou (CAS Key Laboratory of Innate Immunity and Chronic Disease,
School of Life Sciences, University of Science and Technology of China). All mice
except the L2G85.BALB/c mice used in this study are on C57BL/6 background and
were housed in specific pathogen-free conditions in the Department of laboratory
animals of CSU in China. Mice were used between 6 and 12 weeks of age, and only
sex-matched donor–recipient pairs were used. All work was approved and per-
formed according to the Guidelines for Animal Experiments by the Institutional
Animal Care and Use Committee of Central South University.
BMT model. BM transplant recipients were given 5 × 106 BM cells (Biotin antibody
CD90.2, eBioscience; MACS negative sorting, STEMCELL, Canada) after lethal
irradiation with 11 Gy (split doses of 2 × 5.5 Gy apart to 4 h) for the BALB/c→
C57BL/6 combination and 8 Gy (split doses of 2 × 4.0 Gy apart to 4 h) for the
C57BL/6→ BALB/c combinations at CSU, China. T cell doses (Biotin antibodies
CD11b/TER119/B220/CD49b/CD24/CD19b, eBioscience; MACS negative enrich-
ment, STEMCELL, Canada) varied depending on the transplant model C57Bl/6 ≥
BALB/c (8 × 105) and BALB/c ≥C57Bl/6 (2–5 × 106).
Histopathology scoring of acute GVHD. Slides of small bowel and large bowel
samples collected on day 14 were stained with hematoxylin/eosin and scored by
experienced pathologists blinded to the treatment groups. Our GVHD grading
system was as follows: liver—grade 0.5, focal portal lymphoid infiltrate; grade 1,
widespread portal lymphoid infiltrate; grade 2, focal bile duct invasion or cellular
injury; grade 3, multiple foci of bile duct injury and regeneration; grade 4, widespread
injury and destruction of bile ducts. Small and large intestines—grade 0.5, occasional
or rare necrotic cells in glands or crypts; grade 1, multiple foci of necrotic cells in
glands or crypts; grade 2, necrosis involving several crypts or glands with focal
abscess formation in crypts; grade 3, widespread crypt abscesses with focal glandular
destruction; grade 4, loss of mucosa with granulation tissue response.
T cell lymphoma model. To investigate GVL activity of transferred donor T cells, we
used luciferase transgenic EL4 (EL4-luc) T cell leukemia that had been previously
demonstrated to migrate primarily to the BM, with secondary infiltration of the spleen
and other lymphoid organs when injected intravenously at the time of BMT. BALB/
c→ B6 recipients received 5 × 103 luciferase/neo plasmid-transduced EL4 T cell
lymphoma cells (EL4-luc) at the time of BMT. Tumor mortality and GVHD mortality
were distinguished by BLI for tumor load and weight loss indicative of GVHD. BLI
data were analyzed and quantified using the Living Image Software (Xenogen).
Chemotherapy treatment. Mice received BU (10mg kg−1 day−1 from days –7 to –4;
Busilvex, Pierre Fabre Pharma, Germany) and CY (100mg kg−1 day−1 from days −3
to−2; Endoxan, Baxter Healthcare, USA) i.p. (BU/CY). Day of stem cell injection was
assigned as day 0 and the days before stem cell injection are numbered backwards.
Drug treatment. The mice were injected i.p. with 4 µg per mouse a monoclonal
anti-mouse IL-1α antibody (Ab) (BioLegend, Germany) or isotype control Ab (rat
IgG2a, BioLegend, Germany) in 100 µl of NS 24 h before TBI (total body irra-
diation) and 24 h after BMT.
BLI imaging. For BLI studies, mice were injected i.p. with luciferin (10 µg g−1 body
weight). Ten minutes later mice were imaged using an IVIS100 charge-coupled
device (CCD) imaging system (Xenogen, Alameda, CA) for 5 min. Expansion was
quantified in photons s–1 cm–2. Imaging data were analyzed and quantified with
Living Image Software (Xenogen)
Conventional histology and immunohistochemistry. Paraffin-embedded sections
of 5-µm thickness were mounted on microscope slides. After fixing, the primary Ab
(anti-MPO Abs, Abcam, USA) was applied. Sections were then incubated with a
specific secondary biotinylated Ab. Streptavidin horseradish peroxidase and 3,3′-dia-
minobenzidine (Abcam, USA) were used according to the manufacturer’s instructions,
and sections were counterstained with hematoxylin (Thermo Scientific, USA).
Cytokine measurements. The levels of IL-1α and IFN-γ were analyzed from the
serum with the eBioscience Inflammation Kit (eBioscience, USA) and used
according to the manufacturer’s instructions.
Isolation of lamia propria lymphocytes. Mice were sacrificed and intestines were
flushed with PBSCa-/Mg- after dissection of fat and mesenteric tissue and excision of
Peyer’s patches. Pieces (0.5 cm) of longitudinally opened and PBSCa-/Mg-washed
intestine were incubated with Hank's balanced salt solution (HBSS) containing 2mM
EDTA, 10mM HEPES, 5% fetal bovine serum (FBS), and 1mM dithiothreitol. After
15min of incubation on a shaker at 37 °C, intraepithelial lymphocytes and epithelium
were separated via 100-µm filters. Tissues were digested in the HBSSCa+/Mg+ medium
(Thermo Fisher Scientific) containing 10mM HEPES, and 5% FBS at 37 °C in a 5%
CO2 incubator for 0.5 h. Then, intestinal lamia propria lymphocytes (LPLs) were
isolated using the gentleMACS Program m_intestine (gentleMACS Dissociator #130-
093-235) and Intestinal LPL Isolation Kit (Lot: 130-097-410, Miltenyi, Germany).
Flow cytometry. Staining was performed in the presence of purified Ab to CD16/
32 at saturation to block nonspecific staining. For flow analysis, cells were lysed and
fixed with 1× PhosphoFlow Lyse/Fix Buffer for 15 min at 37 °C, and then per-
meabilized with PhosFlow Perm Buffer III on ice for 1 h (all reagents were from
eBioscience USA).
Proximity-ligation assay. PLA Kit (Sigma, USA) was used to study the interaction
between LPS and caspase-11 in mouse intestinal tissue. This unique method is able
to visualize molecular interactions in situ. After fixation with 4% formaldehyde and
permeabilization with 0.1% Triton for 10 min, cells were then incubated overnight
with primary antibodies against LPS (mouse monoclonal 2D7/1) or caspase-11 (rat
monoclonal 17D9). Briefly, after incubation with primary antibodies, cells were
incubated with a combination of corresponding PLA probes, and secondary
antibodies were conjugated to oligonucleotides (mouse PLUS and rat MINUS for
LPS and caspase-11 interaction). Subsequently, ligase was added forming circular
DNA strands when PLA probes were bound in close proximity, along with poly-
merase and oligonucleotides to allow rolling circle amplification. Fluorescent dye-
labeled probes complementary in sequence to the rolling circle amplification
product were hybridized to the rolling circle amplification product. Thus, each
individual pair of proteins generated a spot that could be visualized using fluor-
escent microscopy. Images were taken using a Leica confocal laser scanning
microscope and analyzed using the ImageJ software. In some experiments, cells
were incubated with antibodies against mouse pan-cytokeratin (Clone: AE1/AE3,
Lot: 2086277; Thermo, USA), the epithelial marker, after PLA procedure.
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Immunoblot. Proteins were extracted from intestinal tissues. Protein samples were
separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred onto PVDF membranes (Millipore). Antibodies against mouse
GSDMD (Abcam, USA) was used at 1:1000. Blots were normalized to β-actin (CST,
USA) expression.
Statistical analyses. All data were analyzed using the GraphPad Prism software
(version 6.01). Data were analyzed using Student’s t test for comparison between
two groups. Survival data were analyzed using the log-rank test. A p value < 0.05
was considered statistically significant for all experiments. All values are presented
as the mean ± SEM (error bars).
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its Supplementary Information Files or from the corresponding author
upon reasonable request.
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